Click here for The Motley Fool's resources on Coronavirus and the market.

Progenics Pharmaceuticals

PGNX

PGNX
Progenics Pharmaceuticals Stock Quote
$3.69 $0.10 2.8%
Price as of March 30, 2020, 4:30 p.m. EDT View Interactive PGNX Charts

A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases.

Interactive Chart


News & Analysis: Progenics Pharmaceuticals

The Fool has written over 100 articles on Progenics Pharmaceuticals.

All

Market Moves

Earnings